Skip to main content
. 2018 Apr 18;6(2):33. doi: 10.3390/medsci6020033

Table 1.

Brief etiology and the direct/indirect involvement of MPO in different types of diseases.

No. Name of Disease Brief Etiology and Possible Role of MPO Reference
1 CVD and atherosclerosis Raised level of MPO causes RBCs deformability, accumulation of cholesterol and its esters, ruptures in atherosclerotic plaque [8,60]
2 Obesity Neutrophil infiltration and activation of MPO in adipose tissue [84,85]
3 Neurodegenerative diseases Release of neurotoxic mediators by many factors spearheaded by MPO from neurons, astrocytes, microglia cells [11]
4 Cancer MPO-derived ROS/RNS react with major biomolecules causing mutagenesis, gene polymorphism, SNPs, acrolein-protein adduct formation [86,87,88]
5 Diabetes/diabetic retinopathy Neutrophil activation and the release of MPO in vessels and retina, upregulation of leukocyte adhesion molecules, and increased production of anti-MPO antibodies [89,90]
6 Renal diseases MPO-initiated HOCl-modified proteins in glomerular peripheral basement membranes [91]
7 Liver diseases Neutrophil infiltration, hepatic fibrosis by activation of Kupffer cells cause production of oxidants, impaired signaling events [92,93]
8 Lung injury Activation and expression of proinflammatory cytokines and mediators by MPO [5]
9 Cystic fibrosis Bacterial infiltration, especially Pseudomonas aeruginosa and infiltrating neutrophils [94]
10 Multiple sclerosis MPO-generated ROS cause axonal damage by proteolytic enzymes and cytotoxic oxidants by activated immune cells and glia [95]
11 Alzheimer’s disease Increased production of oxidants like advanced glycation end products, o,o′-dityrosine, lipid oxidation products, protein carbonyls, oxidized DNA, and 3-nitrotyrosine in neuronal tissues proposed by increased expression of MPO [96]
12 Parkinson’s disease Upregulation of MPO and its byproduct, 3-chlorotyrosine, in ventral midbrain [97]
13 Tuberculosis Enhanced MPO expression along with TNF-α and IL-12 activation [98]
14 Asthma Excessive MPO release from neutrophils in lower respiratory tract cells [99]
15 Rheumatoid arthritis Inflamed synovium intervened by lymphocytes and neutrophils leads to the release of proinflammatory mediators [100,101]
16 Chronic sinusitis Enhanced level of MPO and IL-8 in sinuses [102]
17 Peptic ulcer Free radicals formation initiated by MPO [103]
18 Gastric ulcer Neutrophil infiltration and the release of MPO into gastric mucosal tissue [104]
19 Duodenal ulcer MPO and other pro-inflammatory agents [105]
20 Colitis Increased activity of MPO and pro-inflammatory mediators like IL-1β and TNF-α [106,107,108]
21 Pancreatitis Increased MPO activity causes increased ROS that leads to this disease [109]
22 Chronic periodontitis Increased MPO activity in gingival crevicular fluid [110]

MPO: myeloperoxidase; CVD: cardiovascular disease; RBCs: red blood cells; ROS: reactive oxygen species; RNS: reactive nitrogen species; SNP: single nucleotide polymorphism; IL: interleukin; TNF-α: tumor necrosis factor-α. The descriptions of some of the diseases through the perspective of MPO are reviewed in this paper.